Nuvalent

+$0.62 (+7.25%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nuvalent and other ETFs, options, and stocks.

About NUVL

Nuvalent, Inc. operates as a preclinical stage biopharmaceutical company. The company creates precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets.

CEO
James R. Porter
Employees
40
Headquarters
Cambridge, Massachusetts
Founded
2017

NUVL Key Statistics

Market cap
443.04M
Price-Earnings ratio
—
Dividend yield
—
Average volume
167.63K
High today
$9.74
Low today
$8.62
Open price
$8.62
Volume
351.81K
52 Week high
$40.82
52 Week low
$7.09

NUVL Earnings

-$3.17
-$2.11
-$1.06
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.36 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure